Dr. Tarul Kode is Vice President of Partnerships & Alliance Management at Persephoni Bio,
where she shapes how biotech and philanthropy work together to deliver enduring impact for
patients and communities. Persephoni is a hybrid venture studio and private equity platform
advancing breakthrough therapies across oncology, immunology, and rare disease. In her role,
Tarul leads Persephoni’s highest-priority strategic partnerships across industry, academia,
philanthropy, and the broader innovation ecosystem, working to build durable, values-aligned
collaborations and long-term value creation. She also plays a leadership role in Persephoni’s
philanthropic and public-benefit efforts, focused on advancing early biomedical research,
prevention, and early detection.
A healthcare and life sciences executive, board member, advisor, and angel investor, Tarul
brings more than two decades of experience across clinical care, venture partnerships,
investing, and advising healthcare organizations and startups. Her work centers on supporting
purpose-driven leaders and building ecosystems where innovation, accountability, and
real-world impact reinforce one another.
Tarul also serves on boards or advises several mission-aligned organizations, including
Executive Women in Bio, Women Leaders of the World / How Women Lead, CSweetener by
HLTH Foundation, and Springboard Enterprises. She was named one of the 2025 BLOC100
Most Impactful Women of Color and Allies in biopharma, healthcare, and life sciences.
She holds a Doctorate in Pharmacy (cum laude), completed Harvard Medical School’s
Executive Global Health Care Leaders Program (Cohort 1), and is an alumna of VC University
through Berkeley Law, NVCA, and Venture Forward.
Based in the greater Seattle area, Tarul is also a mother of two teenagers, grounding her
leadership in service, accountability, and responsibility to the next generation.
